Dr. Greg Vigna Spinal cord stimulators are linked to over 80,000 injuries, with lead migration and hematomas causing severe harm <b ...
Shares of Boston Scientific Co. (NYSE:BSX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the twenty ...
A range of spinal cord stimulators have been approved by the FDA, but none specifically for SCI patients. Abbott, Medtronic and Boston Scientific all have products indicated for chronic pain.
Despite macroeconomic concerns, currency headwinds and related cost inflation, Boston Scientific Corporation BSX is seeing strength across target markets. The company is demonstrating growth backed by ...
International Assets Investment Management LLC lowered its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 95.3 ...